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 Biocatalysts derived from biological molecules such as proteins, RNA, and DNA have 
long been exploited for applications in synthetic chemistry. Lipases, a versatile class of 
biocatalysts, are known to exhibit significant promiscuity for non-native substrates in non-
aqueous and mixed organic/aqueous solvents. While lipases are known to possess catalytic 
activity for a wide range of organic transformations, predicting which lipases will catalyze 
specific carbon-carbon bond forming reactions remains a significant challenge. In this study, the 
catalytic potential of a library of commercially available lipases was investigated by screening 
them for catalysis of the Robinson Annulation, a synthetically important carbon-carbon bond 
forming reaction. Specifically, the lipase library was screened for synthesis of the Wieland-
Miescher Ketone, an important intermediate in the synthesis of biologically active compounds 
such as steroids and terpenoids, from methyl vinyl ketone and 2-methyl-1,3-cyclohexanedione.  
An optimized procedure is presented for Wieland-Miescher Ketone synthesis using a crude 
preparation of porcine pancreatic lipase (PPL), reporting on both yield and enantiomeric excess. 
Finally, commercially available lipases are often sold as crude preparations, containing many 
different proteins, and are often used by many researchers without further purification, 
 
 
potentially obscuring the identity of the catalytic species. Therefore, a methodology to isolate 
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CHAPTER 1: INTRODUCTION AND BACKGROUND 
1.1 Biocatalysis in Organic Synthesis 
The world of synthetic chemistry has been revolutionized by transition-metal based 
catalysts, which allow scientists to control stereochemistry and perform complex chemical 
reactions.1,2  However, these have several drawbacks including high cost, toxicity, and adverse 
environmental effects.  As a result, chemists have been exploring the potential of biocatalysts as 
less expensive and non-toxic alternatives to the traditional transition-metal based catalysts, while 
also promoting green chemistry at the same time.1-4  Biocatalysts are a group of molecules 
derived from biological molecules such as proteins, RNA, and DNA.  They can be generated in 
large quantities, and obtained from a wide variety of sources including plant, mammalian, 
fungal, and bacterial species using traditional molecular biological methods.1,2  These enzymes 
(biocatalysts) are already being utilized in the industrial settings, particularly in the 
pharmaceutical industry.3  Recently, a U.S. EPA award-winning study conducted by protein 
engineering company Codexis employed an enzyme (halohydrin dehydrogenase) to synthesize 
an atorvastatin (cholesterol lowering drug) intermediate on an industrial scale with high yields 
and enantiomeric excess.4   
 Within this group of biocatalysts is a versatile class of enzymes called lipases, which 
have been studied extensively in the past two decades.5  Lipases have been reported to function 
in non-aqueous media/organic solvents, possess the catalytic ability for a wide range of organic 
reactions, and provide recyclability via immobilization.1,5,6,7  Specifically, lipases are a subclass 
of esterase that catalyze the hydrolysis of esters from triacylglycerides under in vivo conditions 
(high abundance of water) (Figure 1A).  When lipases are under very low or no-water 
conditions, they can function alongside non-aqueous nucleophiles to catalyze various types of 
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organic transformations such as Michael addition and Aldol addition (Figure 1B,C).6,8-11  
Several different previous studies performed under ex vivo conditions have demonstrated that 
lipases catalyzed unexpected chemical reactions, therefore, deeming these catalysts as 
“promiscuous”.12,13  Hult and Berglund further described the promiscuity by breaking it down 
into three different types: condition, substrate, and catalytic.12   
 
Figure 1. Native and “promiscuous” transformations catalyzed by lipases. A. Native lipase 
transformation catalyzed in the aqueous environment. B. Michael addition catalyzed by lipase in 
non-aqueous environment (solvent free).8 C. Aldol addition catalyzed by lipase (acetone/0-55% 
H2O).





The “condition promiscuity” pertains to enzymes with catalytic activity in reaction 
conditions different from their natural ones.  There have been thousands of studies that 
demonstrated enzymes which possess condition promiscuity can catalyze reactions conducted in 
organic solvents, in the absence of solvents, and at extreme temperatures (< 15 °C and >80 °C) 
or pH (< 2 and > 10).14-17  When an enzyme shows broad substrate specificity, it is deemed to 
possess “substrate promiscuity”.18-21  The “catalytic promiscuity” refers to the ability of an 
enzyme’s active site to catalyze different chemical transformations other than its native reaction.  
The “catalytic promiscuity” of lipases has been the foundation over which various studies have 
been conducted to demonstrate a broad spectrum of lipase catalyzed organic transformations.22-27  
Additionally, in organic solvents the lipases are known to catalyze a wide variety of base-
activated carbon-carbon bond forming reactions, where histidine on the lipase acts as the base.  
These chemical interactions have been extended and applied to various carbon-carbon bond 
forming reactions including but not limited to the Robinson annulation, the Knoevenagel 




Figure 2. Examples of previously reported carbon-carbon bond forming reactions catalyzed by 
lipases. A. Robinson Annulation: reaction between 2-methyl-1,3-cyclohexanedione 1 and methyl 
vinyl ketone 2 results in bicyclic products 3 and 4 also known as Wieland Miescher Ketone. B. 
Morita-Baylis-Hillman: reaction between 2,4-dinitrobenzaldehyde 5 and cyclohexenone 6 results 
in MBH products 7 and 8.  C. Knoevenagel Condensation: reaction between 2-oxindole 9 and 4-
nitrobenzaldehyde 10 results in KC products 11 and 12. 
 
1.2 Synthesis of Wieland Miescher Ketone via Robinson Annulation 
The Robinson Annulation reaction, named after the chemist (Robert Robinson) who first 
reported the transformation in 1935, has been heavily utilized throughout the years as a synthetic 
tool to produce six-membered rings in polycyclic compounds.30,31  The term “annulation” means 






reaction between α, β-unsaturated ketones and aldehydes or ketones.  Since its initial report, the 
Robinson Annulation reaction has been studied and applied extensively to produce various 
polycyclic compounds which act as either starting materials or intermediates for synthesis of 
many natural products.  One example of those polycyclic compounds is the Wieland Miescher 
Ketone as previously mentioned (Figure 2A). 
Synthesis of WMK via Robinson Annulation has had a tremendous impact on the field of 
organic synthesis, as it has provided chemists with a great synthetic tool to explore different 
reaction paths for various organic compounds.  Interestingly, the Robinson Annulation is a 
simple yet very important reaction which involves combination of two commonly used organic 
transformations: Michael Addition and Aldol Condensation (Figure 3).  Specifically, for the 
synthesis of Wieland Miescher Ketone, the reaction begins with the Michael Addition step, 
where the α,β-unsaturated ketone(methyl vinyl ketone 2) goes under a nucleophilic attack by the 
activated 2-methyl-1,3-cyclohexanedione 1 to produce the triketone 13.  This Michael product 
then acts as the starting material for the subsequent step, Aldol Condensation, in the Robinson 
Annulation reaction cascade.  During the second segment of Robinson Annulation reaction, the 
triketone intermediate goes through an intramolecular aldol condensation producing an enolate 
14.  The hydroxide ion is expelled through dehydration step producing both enantiomers of the 




Figure 3. Wieland Miescher Ketone synthesis scheme.   
The Wieland Miescher Ketone, named after the two chemists who first reported its 
synthesis in 1950, is a bicyclic α, β-unsaturated cyclic ketone.32  Throughout the years, the 
synthetic potential of WMK has been explored by many scientists.  The presence of two rings 
(AB ring structure) makes it a very versatile building block for synthesis of many different 
compounds such as steroids, terpenoids, Taxol, and other natural products.  WMK has many 
applications in synthesis of complex organic compounds, especially in the pharmaceutical 
industry.  The importance of WMK could not be emphasized enough, as many studies have been 
reported where biologically important steroids, anticancer compounds, and other natural products 










1.3 Research Relevance and Objective 
 
 Recent advancements in molecular biotechnology and protein engineering40,41, along with 
increasing interest for “green chemistry” has led to an emergence of biocatalysts being adopted 
as an alternative catalyst for organic transformations.42  Specifically, lipases have been 
extensively researched for synthesis of different organic compounds.  A generally accepted 
mechanism of lipase catalysis, as described by Hult and Berglund, is that the active site 
responsible for native function of hydrolysis also plays a major role in the promiscuous catalysis 
of organic reactions.12  The catalytic triad present in the active sites are believed to be the driving 
force of catalysis in enzymes, where they create electronic environment conducive to the 
activation of a specific substrate initiating the reaction.  The term catalytic triad refers to a set of 
three amino acids commonly found in active sites of enzymes: histidine, aspartic acid, and 
serine.43  The active sites provide an oxyanion hole which are very crucial for stabilization of the 
high energy oxyanion intermediates or transition states during a reaction.  The oxyanion hole is 
basically a pocket that consists of backbone amides or positively charged residues which would 
stabilize the negative charge on a deprotonated oxygen or alkoxide in the transition state.  This is 
where the presence of serine in the catalytic triad becomes important, as it contains a neutral 
polar side chain.  The hydroxy side chain in serine creates a positively charged 
microenvironment to stabilize the high energy negatively charged transition states, and also act 
as an anchor through catalysis.44 
 The mechanism for Porcine Pancreatic Lipase-catalyzed Robinson annulation reaction, 
proposed by Lai and Zhang, is shown in Figure 4.  The proposed mechanism starts with the first 
step of Robinson Annulation, which is Michael reaction, in the active site consisting of the 
catalytic triad.  The 2-methyl-1,3-cyclohexanedione is activated via deprotonation by His264-
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Asp177 amino acid pair to form an enolate nucleophile.  The carbonyl on methyl vinyl ketone 
interacts with the oxyanion hole in the active site increasing its electrophilic ability.  The 
activated enolate performs a nucleophilic attack on the methyl vinyl ketone followed by proton 
transfer producing the intermediate b. The next step involves deprotonation by the His264-
Asp177 pair to form an enolate anion, influenced by the stabilizing effects of the oxyanion hole.  
This enolate anion goes under intramolecular Aldol Condensation to produce the aldol adduct c.  
Finally the aldol adduct underwent dehydration resulting in the desired product d, Wieland 
Miescher Ketone(WMK).        
 
Figure 4. Proposed mechanism for PPL-catalyzed Robinson annulation for WMK synthesis.29 
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 Based on previously reported results it is hypothesized that lipases proceed to catalyze 
the Robinson Annulation reaction through their active site.  The objective of this research is to 
screen a library of lipases, consisting of some lipases with previously reported promiscuity while 
others with unknown catalytic activity for synthesis of WMK.  Also, it is the hope of this 
research to characterize the lipases that show promising catalytic promiscuity towards synthesis 
of WMK, for future application of directed evolution or enzyme engineering to maximize the 
lipases activity for possible industrial application20,40,41.  Finally the last objective of this research 
is to better understand the role of active site in lipase promiscuity towards organic transformation 
such as the Robinson Annulation.  
Different biocatalysts had been previously reported to catalyze the Robinson Annulation 
reaction.  In the original biocatalytic preparation of WMK, the triketone Michael product from 
the first step of the Robinson Annulation was synthesized using traditional organic catalysts, and 
then isolated.  The isolated Michael adduct was then reacted in organic solvent along with 
organocatalysts such as L-Proline and its analogues to produce Wieland Miescher Ketone via 
intramolecular aldol condensation as a mixture of enantiomers.  Isolating one of the enantiomers 
is a very challenging task, which generally requires additional processing after the initial 
synthesis of a racemic mixture.  One of the many reasons for producing one or the other 
enantiomers is pharmaceutical application and natural product synthesis.  Although they might 
be the same molecule with the only difference being in their stereochemistry, this difference is 
very critical in the efficacy of drugs where one enantiomer could help alleviate a health problem 
while the other could have harmful side effect.  Since WMK is a very important and versatile 
starting material for synthesis of many natural and pharmaceutical products as mentioned 
previously, it is imperative that efficient methods to synthesize it be explored.  Interestingly in 
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the past couple of decades, biocatalysts such as lipases have caught the attention of organic 
chemists for synthesis due their ability to provide great control over stereoselectivity.
 
CHAPTER 2: SCREENING OF LIPASE LIBRARY FOR SYNTHESIS OF WIELAND 
MIESCHER KETONE 
2.1 Assembly of Lipase Library 
 The study began by assembling a 14-member library of  commercially obtained lipases.  
The library consisted of lipases that had been previously reported to catalyze C-C bond forming 
reactions such as porcine pancreatic lipase (PPL) and Candida Antarctica lipase B8,28,29, in 
addition to lipases with unknown biocatalytic properties for promiscuous biocatalysis such as 
wheat germ lipase (WGL).  The library consisted of lipases originating and extracted from 
different species such as bacterial, fungal, plant, and mammals (Table 1).  
Table 1. Commercially obtained lipase library 
Lipase Code Lipase  Origin Sigma Aldrich Catalog Number 
L1 Porcine Pancreatic Lipase Mammalian L3126 
L2 Rhizopus Oryzae Fungal 62305 
L3 Wheat Germ Lipase Plant L3001 
L4 Candida Rugosa Fungal L1754 
L5 Aspergillus Niger Fungal 62301 
L6 Aspergillus Oryzae Fungal L4277 
L7 Pseudomonas Cepacia Bacterial 62309 
L8 Candida Sp. Fungal L3170 
L9 Rhizopus Niveus Fungal 62310 
L10 Mucor Miehei Fungal 62298 
L11 Mucor Javanicus Fungal L8906 
L12 Candida Antarctica B Fungal 62288 
L13 Candida Antarctica A Fungal 62287 




2.2 Screening of Lipase Library  
 The biocatalytic potential of our lipase library was assessed by screening the lipases for a 
one-pot synthesis of WMK from methyl vinyl ketone and 2-methyl-1,3-cyclohexanedione using 
previously reported literature conditions.29  Interestingly, after 48 hours of reaction it was noted 
that each of the reaction mixtures had varying degree of brownish-orange color, possibly 
indicating that product had formed.  Reaction progress was monitored using TLC upon 
completion of reaction after 48 hours.  TLC analysis showed spots for product along with one of 
the starting materials (methyl vinyl ketone), indicating that reaction had consumed all the 
limiting starting material (2-methyl-1,3-cyclohexanedione).  LC/MS method was adopted to 
quickly assess the yields of biocatalyzed reaction.  Using WMK standard, an LC/MS method was 
developed (Experimental Section) to detect only the main fragmentation pattern for the WMK 




Figure 5. HPLC chromatograms from LC/MS analysis.  Top left: WMK standard.  Top right: 
Lipase L1 (Porcine Pancreatic Lipase, PPL).  Bottom left: Lipase L3 (Wheat Germ Lipase, 
WGL).  Bottom right: Lipase L7 (Pseudomonas Cepacia).  The overlaying peaks with different 
color in each chromatogram represent the eight most abundant ion pairs from MS fragmentation.  
Target mass (m/z) = 178.10 
 
  A series of standard solutions were used to generate a standard curve (Figure 6) on the 




Figure 6. Wieland Miescher Ketone standard curve used for quantification of yields 
  
 The LC/MS data for reaction samples was quantified and their reaction yields can be seen 









Table 2. Screening of lipase library for synthesis of Wieland Miescher Ketone 
Entry Lipase Code Lipase Name Yield(ng/µL)a Yield(%)a 
1 L1 Porcine Pancreatic Lipase(PPL) 6140 <1 
2 L2 Rhizopus Olyzae 92 <1 
3 L3 Wheat Germ Lipase(WGL) 2880 <1 
4 L4 Candida Rugosa 269 <1 
5 L5 Aspergillus Niger 591 <1 
6 L6 Aspergillus Oryzae 242 <1 
7 L7 Pseudomonas Cepacia 59 <1 
8 L8 Candida Sp. 148 <1 
9 L9 Rhizopus Niveus 457 <1 
10 L10 Mucor Miehei 211 <1 
11 L11 Mucor Javanicus 331 <1 
12 L12 Candida Antarctica “B” 15 <1 
13 L13 Candida Antarctica “A” 77 <1 
14 L14 Pseudomonas Fluorescens 648 <1 
a The yields were determined by LC/MS 
 
Figure 7. Quantification of data for lipase library using the standard curve shown in Figure 6.  
Reaction conditions:  The following reagents were mixed in a centrifuge tube for one-pot 
synthesis of Wieland Miescher Ketone: methyl vinyl ketone (81 µL, ), 2-methyl-1,3-
cyclohexanedione (23 mg), water (100 µL), and lipase (5 mg).  After all the reactants were 
assembled, the centrifuge tubes were placed in an incubator shaker (30 °C, 250 rpm) for 48 















Wieland Miescher Ketone Yield 
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 The results from screening study showed some lipases (Entries 1, 3, 5, and 14 in Table 2) 
possessed biocatalytic activity, but none of the yields were above 1%.  Interestingly, the 
literature report from which the reaction conditions were obtained had reported yields of up to 
95% using Porcine Pancreatic Lipase as the biocatalyst.29  Although reaction yields from the 
screening study were all below 1%, it is important to note that out of all the lipases screened the 
minimal yet best yield was achieved using PPL; the biocatalyst which resulted in 95% yield in a 
literature report using the same conditions.  Besides PPL (L1), there were other lipases such as 
L3, L5, L9 and L14 (Figure 7 and entries 3, 5, 9, and 14 in Table 2) which also produced WMK 
3 and 4.   
 
2.3 Identification of the Primary Components of Lipase Preparations 
 Lipases are the most commonly used biocatalysts in organic synthesis because of their 
broad specificity for various molecules, and the high degree of regio- and enantioselectivity they 
provide.1-4  However, most of the commercially available lipases are reported to be crude 
preparations, meaning that they contain contaminants such as other proteins.45,46  This could 
create a huge problem since there is no control over which proteins are present in the 
commercially obtained lipase.  The presence of other contaminant proteins could possess some 
form of catalytic activity, which could potentially have opposite activities that would make the 
interpretation of the results very difficult.  These contaminants could even hinder the efficiency 
of these commercially available lipases, specifically when being used for organic reactions, by 
causing competing/reverse reactions.  For example, a widely used lipase for biocatalysis, PPL 
(porcine pancreatic lipase), was previously reported to contain other proteins.47  Another study 
17 
 
reported that commercially available crude preparation of PPL contained between 10 and 50 
different enzymes.48  The recent advancements in molecular biotechnology and enzyme 
engineering have tremendous application to optimize the protein to its full potential as previously 
demonstrated in an EPA award winning study.4  The study conducted in collaboration with 
Codexis, a protein engineering company, demonstrated the potential of directed evolution.  The 
researchers in the study evolved a lipase to develop a more efficient catalyst that gave yields for 
an atorvastatin intermediate above 90% on a commercial scale.4  Directed evolution allows 
scientists to modify the lipases or any other enzyme to obtain higher yields and greater control 
over the stereoselectivity of the target product.  But performing directed evolution or applying 
other enzyme engineering techniques requires the identity or peptide sequence of the enzyme of 
interest.  Therefore, it is very important to identify the primary component of the crude lipase 
which is catalyzing the reaction. 
 Since PPL(L1) and WGL(L3) were the biocatalysts that had the best yields of WMK 
from the initial screening, it was important to isolate, identify, and characterize the biocatalytic 
component of those lipases.  That was achieved by separating the crude lipase mixture of both 
the PPL and WGL using size exclusion chromatography with AKTA FPLC.  The resulting 
fractions were analyzed using SDS-PAGE to obtain the desired bands.  Two distinct bands were 
found in SDS-PAGE analysis of fractions from crude PPL (Figure 8A), while many bands were 
found for WGL (Figure 9).  The bands were excised and sent to UNC Proteomics Center for 
mass spectrometry fingerprinting analysis for characterization.  The results (Figure 8B) 
indicated that the lower molecular weight band from Lane 3 in Figure 8A contained truncated 
version of two peptides, Carboxypeptidase A1 and Carboxypeptidase B, while higher molecular 
weight band from Lane 6 in Figure 8A contained peptide Alpha-amylase.  Surprisingly, neither 
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one of the primary components found in the PPL crude preparation was namesake Porcine 
Pancreatic Lipase.  This is very significant as many different studies have reported promising 
results using this commercially available crude preparation of PPL (Type II) and other enzymes 
without any further purification or characterization.29,49  The same method was applied to 
characterize the peptides present in WGL crude preparation, which were identified to be HSP70 
and Phosphoglycerate Kinase (Figure 8B).  Interestingly, none of the identified proteins were 







Figure 8. Identification of primary components of PPL (Porcine Pancreatic Lipase, L1) and 
WGL (Wheat Germ Lipase, L3) preparations. A. The PPL crude preparation was purified using a 
size exclusion chromatography and the resulting fractions were analyzed using SDS-PAGE.  
Two distinct bands were found in crude preparations of PPL, which were then characterized by 
mass spectrometry fingerprinting analysis.  B. Peptides identified from the fingerprint analysis.  
The lower molecular weight band from Lane 3 in (A) contained two proteins (truncated), 
Carboxypeptidase A1 and Carboxypeptidase B.  The higher molecular weight band from Lane 6 
in (A) contained protein Alpha-amylase.  The two proteins identified in the distinct bands from 










Protein disulfide-isomerase [OS=Triticum aestivum] 
Adenosylhomocysteinase [OS=Triticum aestivum] 
Beta-amylase [OS=Triticum aestivum] 
Bands 7-8 
Description 
Adenosylhomocysteinase [OS=Triticum aestivum] 
Protein disulfide-isomerase [OS=Triticum aestivum] 
Beta-amylase [OS=Triticum aestivum] 
Glucose-1-phosphate adenylyltransferase large subunit, chloroplastic/amyloplastic 
[OS=Triticum aestivum] 
Serpin-Z1B [OS=Triticum aestivum] 
Serpin-Z1C [OS=Triticum aestivum] 
Serpin-Z1A [OS=Triticum aestivum] 
Bands 9-10 
Description 
2-Cys peroxiredoxin BAS1, chloroplastic [OS=Triticum aestivum] 
 
Figure 9. Proteins identified from crude lipolytic preparation derived from Wheat Germ.  A. 
Wheat germ lipase preparation was purified using size exclusion chromatography.  The fractions 
were analyzed using SDS-PAGE and numerous proteins were found to be present in the crude 





2.4 Experimental Section 
 All chemicals, substrates, and solvents were purchased from commercial sources (VWR, 
Millipore-Sigma, TCI America, and Fisher Scientific.  Lipases were purchased from Sigma-
Aldrich.  Thin layer chromatography was performed with silica gel 60 F254 plates, purchased 
from EMD chemicals.   
Biocatalysis Reaction Conditions 
 The following reagents were mixed in a centrifuge tube for one-pot synthesis of Wieland 
Miescher Ketone: methyl vinyl ketone (81 µL), 2-methyl-1,3-cyclohexanedione (23 mg), water 
(100 µL), and lipase (5 mg).  After all the reactants were assembled, the centrifuge tubes were 
placed in an incubator shaker (New Brunswick Excella e24; 30 °C, 250 rpm) for 48 hours.   
LC/MS Instrumental Method 
 Liquid chromatography (LC) was performed on a HPLC system (3200 Exion LC100; 
SCIEX Corporation).  5 µL of samples were injected into the reversed-phase Gemini NX-C18 
column (50 × 2.0 mm, 3 µm; Phenomenex, Torrance, CA, USA) by using auto sampler.  The 
mobile phase composition for A was Water/Acetonitrile mixture (95/5, v/v) with 0.1% formic 
acid, and for B was Methanol.  The gradient method was as follows: 100% A for 1 min, decrease 
to 15% over 4 min, hold at 15% for 1 min, increase back to 100% over 1 min, and hold at 100% 
for 3 min.  The flow rate was 0.3 mL min-1 and total run time was 10 min for each sample 
injection.  The column temperature was kept at 35 °C.  The LC elute was introduced into the 
Applied Biosystem Triple Quad API 3200, a triple-quadrupole tandem mass spectrometer 
equipped with a turbo spray ionization source, for quantification of compounds in positive 
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ionization mode.  Detection of the target molecule was performed in a multiple reaction 
monitoring (MRM) mode, and transition of m/z 179.24 to 161.20 was used for detection of 
WMK.  Mass of WMK: 178.23 g/mol.   
Lipase Purification and Proteomics Method 
 Solutions of porcine pancreatic lipase and wheat germ lipase were fractionated on a 
HiPrep 26/60 Sephacryl S-200 HR column connected to an Akta FPLC (GE Healthcare Life 
Sciences).  Protein fractions were characterized via SDS-PAGE stained with SimplyBlue 
SafeStain (ThermoFisher).  The bands of greatest intensity were excised and digested with 
trypsin overnight using a standard in-gel digestion protocol.  The resultant tryptic peptides were 
desalted using a C18 Zip-Tip and applied to a MALDI target plate with α-cyano-4-
hydroxycinnamic acid as the matrix. The sample was analyzed on an AB Sciex 5800 MALDI 
TOF/TOF mass spectrometer (Framingham, MA, USA).  MS/MS spectra were searched against 
Uniprot databases using Mascot version 2.3 (Matrix Science) (Boston, MA, USA) within 
ProteinPilot software version 3.0 (AB Sciex, Framingham, MA, USA). A significance score 
threshold was calculated in Mascot, with ion scores above the threshold considered positive IDs 
(p < 0.05). 
2.5 Summary of Results 
 At the conclusion of this investigation, it was found that Porcine Pancreatic Lipase and 
Wheat Germ Lipase were the two biocatalysts which produced the most amount of the target 
molecule, Wieland Miescher Ketone, from the screening experiment.  The yields from lipase 
library screen were minimal (<1%) in contrast to the literature report that used the same reaction 
conditions.  Interestingly, the biocatalyst PPL which was reported to give 95% WMK yield in 
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that study also gave the best yield out of all the biocatalyst from the screening experiment.  After 
identifying PPL as the top-hit biocatalyst from the screening experiment, it was important to 
characterize the primary component of the crude preparation of lipase.  This was achieved via 
purification of lipase (PPL and WGL) solution using size exclusion chromatography.  The 
resulting fractions were analyzed on SDS-PAGE and two distinct bands were found to be present 
in PPL.  Same method was applied to WGL and the resulting bands from SDS-PAGE analysis 
for both biocatalysts were excised and sent to UNC Proteomics Center for protein identification 
via mass spectrometry fingerprinting analysis.  The results were surprising, as none out of the 
three peptides (Carboxypeptidase A1, Carboxypeptidase B, and Alpha-amylase) found to be the 
principle components of PPL were the namesake Porcine Pancreatic Lipase.  This was a very 
significant finding as there have been numerous reports using this commercially available crude 
preparation of PPL (Type II) for catalyzing organic transformations without any further 
purification or characterization.  Which means that there could possibly be a group of proteins 
contributing towards the overall yields of these biocatalyzed organic reactions.  Identifying the 
primary components of PPL creates many possibilities for future enzyme engineering application 




CHAPTER 3: REACTION OPTIMIZATION 
3.1 Addition of Imidazole as Co-catalyst 
 After identifying PPL as the model biocatalyst for one-pot synthesis of WMK based on 
the lipase library screening results, optimization experiments were undertaken.  To optimize this 
reaction, reaction conditions from a previous study were adopted where one-pot synthesis of 
WMK was achieved using L-proline as organocatalyst in DMSO.50  There were several changes 
to the reaction conditions from the initial screening experiment.  The reaction time was increased 
from 48 hours to 89 hours, reaction temperature was increased to 35 °C, and the solvent was 
switched from methanol to DMSO.  The L-proline reaction sample was included as a positive 
control.  Also, a HPLC method was developed to analyze the samples for optimization 
experiments.  The first set of reactions involved a positive control of L-proline along with the 
top-hit biocatalyst PPL from the screening experiment, and Bovine Serum Albumin. 
Table 3. Reaction yields for L-Proline catalyzed Robinson Annulation 
Entry Biocatalyst Yield(%)a 
1 - n.r. 
2 L-Proline 68.8 
3 PPL 2.6 
4 BSA n.r. 




Figure 10. HPLC chromatograms of L-proline catalyzed Robinson Annulation reaction.  
Reaction conditions: The following reagents were mixed in a centrifuge tube for one-pot 
synthesis of Wieland Miescher Ketone: DMSO (1000 µL), methyl vinyl ketone (19.8 µL, 0.24 
mmol), 2-methyl-1,3-cyclohexanedione (20 mg, 0.16 mmol), L-Proline (6.4 mg), PPL/BSA (5 
mg). After reactant assembly, centrifuge tubes were placed in a shaker (35 °C, 250 rpm) for 89 
hours. 
 
 The results from the positive control study (Table 3 and Figure 10) clearly indicate that 
L-proline was catalyzing the synthesis of WMK with good yield (68.8%), while PPL under the 
same reaction conditions was only able to achieve 2.6% yield.  Interestingly we found that the 
PPL catalyzed reaction in DMSO was producing the triketone Michael product 13, while the L-
proline reaction was producing the expected WMK products 3 and 4.  This was confirmed by Hi-
Res mass spectrometry and proton NMR.  Therefore, we hypothesized that L-proline plays a dual 
role as a biocatalyst where the amino acid stabilized the necessary transition state for conversion 





produce 3 and 4 through dehydration step.  This indicated that an addition of an acidic or basic 
co-catalyst might be necessary to help with the dehydration step to push the reaction forward.  A 
previously reported study had utilized acid to promote the dehydration and push reaction forward 
after the intramolecular aldol condensation step had completed to produce high yields of 
WMK.49  Interestingly, imidazole is the side chain of amino acid histidine, which is a part of the 
catalytic triad present in the active sites of enzymes.  Therefore, it was reasoned that basic co-
catalyst such as imidazole would possibly play a bi-functional role by helping with the activation 
of ketone for the Michael step and also by allowing the reaction to progress forward post-
intramolecular aldol condensation by promoting dehydration and potentially increasing the yield 
of WMK.   
 The next step in reaction optimization was to test the addition of imidazole as co-catalyst 
along with the PPL while keeping the other reaction conditions same.  Reaction samples were 
setup with and without imidazole to test our hypothesis and better understand the role of co-
catalyst in reaction.      
Table 4. Addition of Imidazole as Cocatalyst  
Entry Biocatalyst Cocatalyst(Imidazole) Yield(%)a 
1 - - n.r. 
2 - + n.r. 
3 PPL - 2.6 
4 PPL + 14.4 
5 BSA - n.r. 
6 BSA + 13.4 






Figure 11. HPLC chromatograms corresponding to reaction samples in Table 4.  A. HPLC 
chromatogram of sample with only PPL.  B. HPLC chromatogram of sample with only 
imidazole.  C. HPLC chromatogram of sample with both PPL and imidazole.  Reaction 
conditions: The following reagents/reactants were mixed in each centrifuge tube for synthesis of 
Wieland Miescher Ketone: DMSO (900 µL), methyl vinyl ketone (19.8 µL, 0.24 mmol), 2-













































































imidazole (2.7 mg, 0.04 mmol). After reactant assembly, centrifuge tubes were placed in an 
incubator shaker (35 °C, 250 rpm) for 89 hours.   
 The results clearly indicated the impact of imidazole on the yield after its addition as a 
co-catalyst.  The reaction sample with just the biocatalyst PPL had no product formation as 
clearly indicated by the absence of a peak around 8 minutes in HPLC chromatogram (Figure 
11A).  The reaction sample with just the co-catalyst imidazole also had no product formation as 
indicated by the absence of product peak in the chromatogram (Figure 11B).  Although no 
product was being formed, one of the starting materials had been completed consumed during 
the reaction in the presence of just the imidazole, which was not the case when only PPL was 
present in the reaction mixture.  This is possibly due to imidazole acting as base during the first 
segment of Robinson Annulation reaction and promoting the Michael addition.  That would 
generally be catalyzed by the Histidine amino acid present in the active site as a part of the 
catalytic triad mentioned earlier.  Since imidazole is the side chain of Histidine which plays a 
role in its functionality, the presence of free imidazole in the reaction allowed for the Michael 
reaction segment to go to completion while consuming all of the limiting reagent (2-methyl-1,3-
cyclohexanedione).  Interestingly, when both the PPL and imidazole were present together in the 
reaction mixture, minimal product formation was detected (Figure 11C and entry 4 in Table 4).  
These results indicate that addition of imidazole as co-catalyst could be playing a role in the 
dehydration step of the reaction after the intramolecular aldol condensation step pushing the 
reaction equilibrium towards the product.  Also it is important to note that BSA(bovine serum 





3.2 Catalyst Loading Study 
 The co-catalyst study showed that the presence of imidazole was important along with 
the biocatalyst for product formation.  The next step in reaction optimization was to determine 
the optimal catalyst loading.  Reaction samples with the biocatalyst PPL ranging from 5 to 40 
mg/mL were assembled in DMSO along with the co-catalyst imidazole.  No other reaction 
conditions were changed except the amount of biocatalyst present in the reaction mixture.   
Table 5.  Reaction yields from PPL loading study  
Entry Biocatalyst Catalyst Load (mg) Yield(%)a 
1 PPL 5 14.4 
2 PPL 10 23.9 
3 PPL 15 47.9 
4 PPL 20 51.4 
5 PPL 25 60.4 
6 PPL 30 62.2 
7 PPL 35 51.9 
8 PPL 40 11.2 
a Yields were determined by HPLC 
  
 The results in Table 5 show the yields obtained from the catalyst loading study, where 
the amount of catalyst in each sample was varied from 5 mg/mL to 40 mg/mL.  The results were 
intriguing, as the yields increased in every reaction sample with catalyst loading all the way up to 
30 mg/mL, but started decreasing with higher catalyst loading.  This observed decrease in the 
yield with higher catalyst loading could be contributed mostly to an increased amount of 
insoluble material from the crude lipase preparation in the reaction vials, preventing an efficient 
mixing between the catalyst and the substrates.  This problem could be addressed by applying 
mechanical stirring instead of the shaking during the incubation/mixing period, which might 
result in better yields for the higher catalyst loading samples. 
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3.3 Solvent Effects and Enantiomeric Excess Determination 
 The WMK is a chiral compound, meaning that there are two enantiomers of the molecule.  
Since WMK is a versatile starting material for steroids, terpenoids, and other natural products, 
the stereochemistry of the product being synthesized is very important.  Therefore, a chiral 
HPLC method was developed to determine enantiomeric excess of the WMK being produced by 
lipase catalyzed Robinson Annulation reaction.  Chiral HPLC is a common technique used for 
finding the enantiomeric excess of a sample mixtures.  The peak area for each enantiomer in a 
sample mixture are used to calculate the enantiomeric excess value.  The chiral HPLC 
chromatograms can be seen below in Figure 12 for the standards, L-Proline catalyzed reaction 
sample, and PPL-imidazole in DMSO sample from co-catalyst study.  The product from samples 
was isolated and purified via column chromatography on silica gel with hexanes-ethyl acetate 
(2:1) as the eluting solvent.  The collected fractions were monitored for presence of WMK using 
TLC.  The fractions with the product were combined and excess solvent was evaporated in a 
rotary evaporator, which resulted in a orangish brown oil which was resuspended in methanol for 






Figure 12. Development of Chiral HPLC Method and Determination of Enantiomeric Excess in 
Reaction Samples.  A. Reaction yields from catalyst loading study.  Chiral HPLC 
chromatograms (Chiralcel OD-H column; mobile phase: isopropanol/heptane mixture (20/80, 
v/v) containing 0.1% formic acid) used for enantiomeric excess determination are shown for: B. 
Racemic WMK standard; C. S-WMK enriched standard; D. R-WMK enriched standard; E. 
Purified L-proline catalyzed WMK product; and F. Purified PPL/imidazole in DMSO catalyzed 
WMK product. 
 Having optimized the catalyst loading, the next step in the optimization was to determine 
the optimal solvent that resulted in good yield and enantiomeric excess.  Previously reported 
studies had shown that the polar solvents were generally favored and showed promising results 
for biocatalyzed Robinson Annulation reaction.  Therefore, different solvents were tested while 
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using the conditions optimized so far such as optimal catalyst load (30 mg) and addition of 
imidazole as co-catalyst.  The resulting yields along with enantiomeric excess of WMK products 
can be seen below in Table 6. 
Table 6. Determination of optimal solvent for reactions with PPL and imidazole 
Entry Biocatalyst Solvent Yield(%)a Ee(%)b 
1 L-Proline DMSO 68.8 70.1 
2 PPL-5 mg DMSO 14.4 9.8 
3 PPL-35 mg DMSO 51.8 17.7 
4 PPL-5 mg Methanol 7.3 24.1 
5 PPL-30 mg Methanol 55.1 13.7 
6 PPL-30 mg Ethanol 48.3 10.3 
7 PPL-30 mg Propanol 35.3 8.3 
8 PPL-30 mg Butanol 28.7 6.1 
9 PPL-30 mg Pentanol 29.6 3.6 
a Yields were determined by HPLC 
b Enantiomeric excess determined by chiral HPLC (Chiralcel OD-H column); S-configuration 
 
 The reaction yields in solvents other than DMSO were investigated.    The positive 
control reaction with L-Proline produced good yield and enantiomeric excess of WMK products, 
similar to the literature report.50  In contrast, the yields and enantiomeric excess of WMK 
products produced by the PPL/imidazole in DMSO was substantially lower, but increased after 
the catalyst loading was increased (Entries 1-3 in Table 6).  The reaction with lower catalyst 
load in methanol produced the best enantiomeric excess of WMK products but had a very 
minimal yield of 7.3% (Entry 4 in Table 6).  The reactions in methanol produced yields similar 
to DMSO, but reactions with increasingly longer chain alcohols (ethanol, propanol, butanol, and 
pentanol) showed a steady decrease in the reaction yield (Entries 6-9 in Table 6).  The same 
trend was observed for the enantiomeric excess of WMK products produced in reactions with 
those solvents.  Until this point, it has been determined that the reaction required co-catalyst 
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imidazole to push the reaction forward and promote product formation.  Also the optimal catalyst 
loading (30 mg) and solvent (methanol) were identified for the reaction to produce moderate 
yield and enantiomeric excess of WMK products. 
3.4  Exploration of Co-catalysts 
 Although it had been established that imidazole was improving the reaction yield, it was 
important to explore other co-catalysts.  The optimal PPL loading and solvent were screened 
with different co-catalysts, with each one varying in basicity.  The dimethylaminopyridine 
(DMAP) gave substantially lower yield compared to imidazole, while the ionic base co-catalysts 
sodium hydroxide and sodium bicarbonate gave lower yields than imidazole but not as 
significantly reduced as DMAP (Table 7).  It is important to note that DMAP which is more 
nucleophilic but less basic than imidazole gave a lower yield.  The results indicate that basicity 
of co-catalyst could play an important role especially during the dehydration step after the 
intramolecular aldol condensation.  The co-catalyst’s ability to abstract proton from aldol 
product 14 depends on its basicity.  That correlation can be seen from the results of testing of 
different co-catalysts. 
Table 7. Screening optimal PPL loading with different cocatalyst 
Entry Cocatalyst Solvent Yield(%)a 
1 Sodium Hydroxide Methanol 43.0 
2 Sodium Bicarbonate Methanol 46.5 
3 Imidazole Methanol 55.1 
4 DMAP Methanol 24.5 
a Yields were determined by HPLC 
 
 The reaction conditions were optimized through various experiments to increase WMK 
products yield.  Different solvents were tested to explore any effects on the yield as well as the 
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enantiomeric excess of WMK products.  The optimal catalyst loading was determined to be 30 
mg, and higher catalyst loading than that resulting in a decrease in the product yield.  As the 
carbon chain on alcohol solvents increased, the yields and enantiomeric excess decreased, with 
methanol giving the best results.   
3.5 Rescreening of Biocatalysts using Optimized Reaction Conditions 
 After identifying the optimal catalyst loading, solvent, and basic co-catalyst, the lipase 
library was rescreened to determine the impact of optimized conditions on their biocatalytic 
activity.  In addition to the lipases from the initial screening, commercially available proteins that 
were identified from the proteomics as principal components of crude PPL (carboxypeptidase A, 
carboxypeptidase B, alpha amylase) were also included in the rescreen.  The immobilized forms 
of Candida Antarctica lipase B (Lipase codes: L12-acr and L12-imo) were also added to the 
lipase library.  The results from the rescreening of updated lipase library using optimized 
conditions can be seen below in Table 8.  The samples with the highest yields were further 
purified via column chromatography and the isolated product was used for enantiomeric excess 










Table 8. Rescreening of updated lipase library using optimized reaction conditions 
Entry Biocatalyst Yield(%)a Ee (%)b 
1 L1 51.9 21.7 
2 L2 0.7 - 
3 L3 17.1 1.2 
4 L4 7.2 - 
5 L5 13.5 19.9 
6 L6 0.8 - 
7 L7 1.3 - 
8 L8 n.r. - 
9 L9 16.0 14.4 
10 L11 4.5 - 
11 L12-Acrylic Resin 1.7 - 
12 L12-Immobeads 2.3 - 
13 L14 10.9 (-)1.7 
14 α-Amylase (liquid) 5.3 - 
15 Carboxypeptidase A 0.4 - 
16 Carboxypeptidase B 4.2 - 
17 α-Amylase(solid) 26.4 19.3 
a Yields were determined by HPLC 
b Enantiomeric excess determined by chiral HPLC (Chiralcel OD-H column); S-configuration 
 
 In addition to the HPLC and mass spectrometry screening method, absorbance was 
discovered to be an effective method for a quick screening of biocatalytic potential towards the 
WMK synthesis.  The absorbance (350 nm) of crude reaction mixture was correlated with the 
reaction yield, demonstrating a correlation between biocatalytic potential and yield of WMK 
from HPLC (Figure 13A).  Additionally, plotting absorbance (350 nm) versus percent yield 
revealed that if a colorimetric cutoff of OD350 = 1.0 was applied, all the reactions with yields 
below 10% would be eliminated (Figure 13C).  This demonstrates that colorimetric analysis 
could be very convenient and quick approach towards a large-scale screen of biocatalysts for 




Figure 13.  Rescreening of Lipase Library using Optimized Conditions.  A. Image of reaction 
samples after 89 h (top); absorbance of crude reaction samples at 350 nm (middle); and reaction 
yields (Table 8) from rescreening of updated lipase library (bottom).  Error bars were 
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determined from replicate HPLC injections. B. Wavelength scan of crude reaction sample 
absorbance. C. Plot of absorbance at 350 nm versus reaction yield. 
 Comparing the reaction yields from the rescreen (Table 8) with the initial screening 
(Figure 7) revealed that the biocatalysts which were identified as top hits from the initial LC/MS 
screen (L1, L3, L5, L9, and L14) were also the top biocatalysts in the colorimetric screening 
method (Figure 13).  Out of the three principal components identified in the crude PPL 
preparation, only alpha amylase produced a significant yield of WMK while the other two 
proteins (carboxypeptidase A and carboxypeptidase B) have very minimal yield.  Interestingly 
the yield was not similar to that of crude PPL preparation, indicating that multiple proteins 
maybe involved in the catalysis of Robinson Annulation reaction.  It is important to note that a 
non-lipase protein (BSA) had shown product formation (Entry 6 in Table 4) in the presence of 
imidazole as co-catalysts.  Based on these observations, we hypothesized that the endogenous 
catalytic activity of proteins present in lipase preparations was not contributing to product 
formation as previously reported.29 
3.6 Experimental Section 
 All chemicals, substrates, and solvents were purchased from commercial sources (VWR, 
Millipore-Sigma, TCI America, and Fisher Scientific.  Lipases were purchased from Sigma-
Aldrich.  Thin layer chromatography was performed with silica gel 60 F254 plates, purchased 






Table 9. Updated Lipase Library 
Lipase 
Code 
Lipase  Catalog Number 
L1 Porcine Pancreatic Lipase L3126 
L2 Rhizopus Olyzae 62305 
L3 Wheat Germ Lipase L3001 
L4 Candida Rugosa L1754 
L5 Aspergillus Niger 62301 
L6 Aspergillus Oryzae L4277 
L7 Pseudomonas Cepacia 62309 
L8 Candida Sp. L3170 
L9 Rhizopus Niveus 62310 
L10 Mucor Miehei 62298 
L11 Mucor Javanicus L8906 
L12 Candida Antarctica B 62288 
L13 Candida Antarctica A 62287 
L14 Pseudomonas Fluorescens 534730 
L12-acr Candida Antarctica B L4777 
L12-imo Candida Antarctica B 52583 
PA Carboxypeptidase A C9268 
PB Carboxypeptidase B C9584 
P alpha Alpha amylase (suspension) 10102814001 








Biocatalysis Reaction Condition 
 The following reagents/reactants were mixed in a microcentrifuge tube for synthesis of 
Wieland–Miescher ketone: solvent (900 µL), methyl vinyl ketone (19.8 µL, 0.24 mmol), 2-
methyl-1,3-cyclohexanedione (20 mg, 0.16 mmol), deionized water (100 µL), and lipase (0–40 
mg) or L-proline (6.4 mg), with or without imidazole (2.7 mg, 0.04 mmol).  After all the 
reactants were assembled, the centrifuge tubes were placed in an incubator shaker (New 
Brunswick Excella e24; 35 °C, 250 rpm) for 89 hours. 
Cocatalyst and Solvent Optimization Reaction Condition 
 The following reagents/reactants were mixed in a microcentrifuge tube for synthesis of 
Wieland–Miescher ketone: alcohol solvent (900 µL), methyl vinyl ketone (19.8 µL), 2-methyl-
1,3-cyclohexanedione (20 mg), deionized water (100 µL), and lipase (L1, 30 mg), cocatalyst 
(0.04 mmol).  After all the reactants were assembled, the centrifuge tubes were placed in an 
incubator shaker (New Brunswick Excella e24; 35 °C, 250 rpm) for 89 hours. 
Hi-Res Mass Spectrometry Analysis of triketone and WMK 
 Samples were analyzed with a Q Exactive HF-X (ThermoFisher, Bremen, Germany) 
mass spectrometer. Samples were introduced via a heated electrospray source (HESI) at a flow 
rate of 10 µL/min. One hundred times domain transients were averaged in the mass spectrum. 
HESI source conditions were set as: nebulizer temperature 100 deg C, sheath gas (nitrogen) 15 
arb, auxillary gas (nitrogen) 5 arb, sweep gas (nitrogen) 0 arb, capillary temperature 250 degrees 
C, RF voltage 100 V, spray voltage 3.5 KV.  The mass range was set to 150-2000 m/z.  All 
measurements were recorded at a resolution setting of 120,000. Solutions were analyzed at 0.1 
mg/mL or less based on responsiveness to the ESI mechanism. Xcalibur (ThermoFisher, 
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Breman, Germany) was used to analyze the data. Molecular formula assignments were 
determined with Molecular Formula Calculator (v 1.2.3). All observed species were singly 
charged, as verified by unit m/z separation between mass spectral peaks corresponding to the 12C 
and 13C12Cc-1 isotope for each elemental composition. 
Characterization of triketone (2-methyl-2-(3-oxobutyl)-1,3-cyclohexanedione): 
 Hi-Res mass spec: m/z = 197.11761 (mass error = 2.0 ppm) Assigned Chemical Formula: 
C11H17O3 [M+H]
+ ; 1H-NMR (400 MHz, CDCl3): 2.60-2.77 (m, 2H), 2.35 (t, 2H), 2.11 (s, 3H), 
2.04-2.08 (m, 2H), 1.89-1.95 (m, 2H), 1.25 (s, 3H). 
Characterization of WMK ((S,R)-(+/-)-8a-methyl-3,4,8,8a-tetrahydro-1,6(2H,7H)-
napthalenedione): 
 Hi-Res mass spec: m/z = 179.10583 (mass error = -4.6 ppm) Assigned Chemical 
Formula: C11H15O2 [M+H]
+; 1H NMR (400 MHz): 5.85 (s, 1H), 2.67–2.76 (m, 2H), 2.38–2.52 
(m, 4H), 2.09–2.19 (m, 3H), 1.65–1.78 (m, 1H), 1.45 (s, 3H). 
HPLC analysis for reaction yield 
 Liquid chromatography was performed on a HPLC system(Waters Corporation) 
consisting of binary pump(1525 Binary HPLC Pump), absorbance detector(2487 Dual 
Wavelength Absorbance Detector), and auto sampler(717-plus Autosampler).  5µL of sample 
were injected into the reversed-phase Xterra MS C18 column (4.6 × 100 mm, 5µm; Waters, 
Milford, MA, USA) using auto sampler.  The samples were analyzed using an isocratic method: 
80% Solvent A(water) and 20% Solvent B(methanol).  The flow rate was 1.0 mL min-1 and the 
total run time was 13 minutes for each sample injection.  The detector wavelength was set to 210 
nm and the retention time for WMK was 7.9 minutes. 
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Chiral HPLC analysis for enantiomeric excess 
 Liquid chromatography for enantiomeric excess was performed on a HPLC 
system(Waters Corporation) consisting of binary pump(1525 Binary HPLC Pump), absorbance 
detector(2487 Dual Wavelength Absorbance Detector), and auto sampler(717-plus 
Autosampler).  5µL of sample were injected into the Chiralcel OD-H column (0.46 cm × 25 cm; 
Daicel, Minato, Japan) using auto sampler.  Isopropanol/Heptane mixture (20/80, v/v) containing 
0.1% formic acid was used as a mobile phase and pumped at a flow rate of 0.1 mL min-1.  Total 
run time was 111 minutes for each sample injection.  The detector wavelength was set to 250 nm 













CHAPTER 4: MECHANISTIC INSIGHT 
4.1 Exploring the effects of biocatalysts inhibitors on reaction yield 
 Based on the results from optimization studies, it was hypothesized that the native 
catalytic activity of the proteins was not responsible for product formation.  To investigate this, 
an experiment was conducted using inhibitors acarbose and orlistat (amylase and lipase 
inhibitors respectively).  The biocatalytic reactions were setup using alpha amylase and PPL in 
the presence of commercially obtained inhibitors acarbose and orlistat.  
Table 10. Biocatalytic reaction in the presence of biocatalyst inhibitors 
Entry Biocatalyst Inhibitor(Acarbose) Inhibitor(Orlistat) Yield(%)a 
1 PPL - - 50.7 
2 PPL +  52.5 
3 PPL - + 54.9 
4 α-Amylase (solid) - - 31.0 
5 α-Amylase (solid) + - 27.4 
6 α-Amylase (solid) - + 27.6 
7 Carboxypeptidase B + α-
Amylase (solid) 
- - 31.9 
a Yields were determined by HPLC 
 
 The results (Table 10) from the inhibitor experiment were very interesting, as the yield 
for PPL in the presence of excess lipase inhibitor had not decreased compare to the reaction 
without the inhibitor.  Interestingly the excess amylase inhibitor did reduce the yield of reaction 
catalyzed by alpha amylase, but only minimal amount.  The intrinsic lipase activity of crude PPL 
preparation was confirmed to be fully inhibited in the presence of orlistat.  This was achieved by 
performing a simple lipase assay monitoring the hydrolytic activity with p-nitrophenylpalmitate 




Figure 14. Effects of inhibitors on lipolytic activity of a crude preparation of PPL. 
4.2 Experimental Section 
Biocatalysis reaction condition 
 The following reagents/reactants were mixed in a microcentrifuge tube for synthesis of 
Wieland–Miescher ketone: solvent (900 µL), methyl vinyl ketone (19.8 µL), 2-methyl-1,3-
cyclohexanedione (20 mg), deionized water (100 µL), and lipase (30 mg), imidazole (2.7 mg, 
0.04 mmol). For reaction involving inhibitors, the biocatalyst was mixed with the inhibitor (5 
mg) for 10 min at room temperature before adding the substrates and cocatalyst. After reaction 
assembly, capped microcentrifuge tubes were placed in a temperature-controlled shaker (New 




Lipase assay for native activity 
PPL (70 mg) was suspended in 3 mL of Tris-Glycerol buffer (13 mM Tris HCl, pH 8, 
150 mM NaCl, 3 mM CaCl2, 5% glycerol) for 10 min, then centrifuged to remove insoluble 
material. The resulting supernatant (1 mL) was then combined with the inhibitor (5 mg Orlistat 
or Acarbose) dissolved in 200 µL of methanol. The resulting solutions were incubated for 10 min 
at room temperature on an end-over-end rotator, then filtered (Millipore centrifugal filter) to 
remove insoluble material. 100 µL of the resulting solutions were then assayed in the presence of 
p-nitrophenylpalmitate (5 µL of a 2.5 mM stock solution in DMSO) with a Molecular Devices 
M2e plate reader (405 nm, readings acquired every 10 s). Assays were performed in triplicate, 
error bars represent S.E.M. 
4.3 Summary of Results 
 Based on the results above, it was concluded that lipase activity is not responsible for the 
promiscuous catalysis observed with crude preparation of PPL.  Additionally, while the reaction 
was shown to be catalyzed by multiple proteins regardless of whether they possess intrinsic 
enzymatic activity, not all proteins were capable of catalyzing WMK product formation as seen 
from the screening results.  While many literature reports have attributed the promiscuous 
biocatalytic activity of PPL directly to the lipase active site, that was not the case based on the 
results discovered in this study.  The generally accepted mechanism for lipase promiscuous 
catalysis is believed to be occurring in the active site of lipase where the catalytic triad is present.  
Based on the results found in this study, the lipase promiscuous catalysis was still happening 
even when the lipase inhibitor (orlistat) was present in the reaction mixture.  This promiscuous 
activity even in the presence of inhibitor could possibly be attributed to the surface exposed 
amino acids which could be catalyzing the Robinson Annulation reaction.  For these biocatalysts 
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to be potentially used in industrial applications, it is important to characterize their mode of 
action.  Interestingly in this study, the crude PPL preparation was found to contain alpha amylase 
as a principal component, which could become a candidate for future optimization.  There are 
several different ways to potentially understand the role of active site possibly via mutagenesis of 
amino acids that are part of the catalytic triad.  Also, alpha amylase could be optimized through 
directed evolution to further increase the yield and stereoselectivity for WMK.  Furthermore, this 
study demonstrated that a quick colorimetric screening can be very useful for large-scale 
screening for identification of biocatalysts that possess promiscuous activity towards WMK 
formation.  This screening methodology could be extended to other variations of Robinson 





CHAPTER 5: CONCLUSIONS 
 In this research different methods for screening commercially available lipases to assess 
their biocatalytic potential for synthesis of Wieland Miescher Ketone were demonstrated.  After 
the initial screening of lipase library, optimization experiments were conducted using PPL as the 
model lipase.  Through optimization experiments, the importance of a basic co-catalyst 
Imidazole was demonstrated for efficient production of Wieland Miescher Ketone.  The yield 
was improved from less than 1% up to 55%.  The enantioselectivity was lower than previously 
reported L-Proline catalyzed WMK synthesis.  Interestingly after identifying the principle 
components of crude preparation of PPL, those proteins could become candidates for future 
studies.  The product yield and enantioselectivity could be further improved by optimizing the 
identified proteins through techniques such as directed evolution or enzyme engineering.  
Colorimetric screening method for assessing biocatalytic potential of lipases was also 
demonstrated, which could be a quick method for future screening of other biocatalysts.  
Furthermore, the screening methods could be applied for a substrate scope study or even 
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